- Home
- WHWK vs CCEL Comparison
WHWK vs CCEL Comparison
Compare WHWK & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- CCEL
- Stock Information
- Founded
- WHWK 2007
- CCEL 1989
- Country
- WHWK United States
- CCEL United States
- Employees
- WHWK N/A
- CCEL N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- CCEL Managed Health Care
- Sector
- WHWK Health Care
- CCEL Health Care
- Exchange
- WHWK Nasdaq
- CCEL Nasdaq
- Market Cap
- WHWK 48.3M
- CCEL 51.9M
- IPO Year
- WHWK N/A
- CCEL 1997
- Fundamental
- Price
- WHWK $1.68
- CCEL $4.94
- Analyst Decision
- WHWK
- CCEL Strong Buy
- Analyst Count
- WHWK 0
- CCEL 1
- Target Price
- WHWK N/A
- CCEL $8.50
- AVG Volume (30 Days)
- WHWK 172.0K
- CCEL 9.7K
- Earning Date
- WHWK 05-08-2025
- CCEL 04-15-2025
- Dividend Yield
- WHWK N/A
- CCEL 8.00%
- EPS Growth
- WHWK N/A
- CCEL N/A
- EPS
- WHWK 0.91
- CCEL 0.01
- Revenue
- WHWK $27,775,000.00
- CCEL $32,102,750.00
- Revenue This Year
- WHWK $30.85
- CCEL $2.49
- Revenue Next Year
- WHWK N/A
- CCEL $0.95
- P/E Ratio
- WHWK $1.87
- CCEL $553.77
- Revenue Growth
- WHWK 16.51
- CCEL 2.33
- 52 Week Low
- WHWK $1.21
- CCEL $4.75
- 52 Week High
- WHWK $3.81
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- WHWK N/A
- CCEL 36.73
- Support Level
- WHWK N/A
- CCEL $4.87
- Resistance Level
- WHWK N/A
- CCEL $5.13
- Average True Range (ATR)
- WHWK 0.00
- CCEL 0.23
- MACD
- WHWK 0.00
- CCEL 0.02
- Stochastic Oscillator
- WHWK 0.00
- CCEL 19.80
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.